BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 23315239)

  • 1. Management of genetic syndromes predisposing to gynecologic cancers.
    Miesfeldt S; Lamb A; Duarte C
    Curr Treat Options Oncol; 2013 Mar; 14(1):34-50. PubMed ID: 23315239
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Screening and prevention of hereditary gynecologic cancers.
    Kehoe SM; Kauff ND
    Semin Oncol; 2007 Oct; 34(5):406-10. PubMed ID: 17920895
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Society of Gynecologic Oncologists Education Committee statement on risk assessment for inherited gynecologic cancer predispositions.
    Lancaster JM; Powell CB; Kauff ND; Cass I; Chen LM; Lu KH; Mutch DG; Berchuck A; Karlan BY; Herzog TJ;
    Gynecol Oncol; 2007 Nov; 107(2):159-62. PubMed ID: 17950381
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Risk-reducing surgery in women at hereditary risk of gynaecological cancer].
    Zikán M
    Ceska Gynekol; 2011 Jun; 76(3):216-21. PubMed ID: 21838153
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost-effectiveness Analysis of Genotype-Specific Surveillance and Preventive Strategies for Gynecologic Cancers Among Women With Lynch Syndrome.
    Wright JD; Silver ER; Tan SX; Hur C; Kastrinos F
    JAMA Netw Open; 2021 Sep; 4(9):e2123616. PubMed ID: 34499134
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gynecologic cancer prevention in Lynch syndrome/hereditary nonpolyposis colorectal cancer families.
    Chen LM; Yang KY; Little SE; Cheung MK; Caughey AB
    Obstet Gynecol; 2007 Jul; 110(1):18-25. PubMed ID: 17601891
    [TBL] [Abstract][Full Text] [Related]  

  • 7. BRCA1/2 mutations and risk-reducing bilateral salpingo-oophorectomy among Latinas: The UPTAKE study.
    Lynce F; Schlam I; Geng X; Peshkin BN; Friedman S; Dutil J; Nahleh Z; Campos C; Ricker C; Rodriguez P; Denduluri N; Ahn J; Isaacs C; Graves KD
    J Genet Couns; 2021 Apr; 30(2):383-393. PubMed ID: 33010199
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prophylactic Gynecologic Surgery at Time of Colectomy Benefits Women with Lynch Syndrome and Colon Cancer: A Markov Cost-Effectiveness Analysis.
    Ofshteyn A; Jiang B; Bingmer K; Nakayama JM; Gallego C; Giglia M; Stein SL; Steinhagen E
    Dis Colon Rectum; 2020 Oct; 63(10):1393-1402. PubMed ID: 32969882
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Experience of risk-reducing salpingo-oophorectomy for a BRCA1 mutation carrier and establishment of a system performing a preventive surgery for hereditary breast and ovarian cancer syndrome in Japan: our challenges for the future.
    Hirasawa A; Masuda K; Akahane T; Tsuruta T; Banno K; Makita K; Susumu N; Jinno H; Kitagawa Y; Sugano K; Kosaki K; Aoki D
    Jpn J Clin Oncol; 2013 May; 43(5):515-9. PubMed ID: 23487443
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management updates for women with a BRCA1 or BRCA2 mutation.
    Nusbaum R; Isaacs C
    Mol Diagn Ther; 2007; 11(3):133-44. PubMed ID: 17570734
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic predisposition in gynecologic cancers.
    Daniels MS; Lu KH
    Semin Oncol; 2016 Oct; 43(5):543-547. PubMed ID: 27899185
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic testing for hereditary cancer predisposition: BRCA1/2, Lynch syndrome, and beyond.
    Hall MJ; Obeid EI; Schwartz SC; Mantia-Smaldone G; Forman AD; Daly MB
    Gynecol Oncol; 2016 Mar; 140(3):565-74. PubMed ID: 26812021
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hereditary breast and ovarian cancer (HBOC): clinical features and counseling for BRCA1 and BRCA2, Lynch syndrome, Cowden syndrome, and Li-Fraumeni syndrome.
    Shulman LP
    Obstet Gynecol Clin North Am; 2010 Mar; 37(1):109-33, Table of Contents. PubMed ID: 20494261
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of genetic testing for cancer susceptibility in gynecologic practice.
    Karlan BY; Berchuck A; Mutch D
    Obstet Gynecol; 2007 Jul; 110(1):155-67. PubMed ID: 17601911
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hereditary gynecologic cancers: differential diagnosis, surveillance, management and surgical prophylaxis.
    Lu KH
    Fam Cancer; 2008; 7(1):53-8. PubMed ID: 17636427
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk-benefit assessment of the combined oral contraceptive pill in women with a family history of female cancer.
    Davidson BA; Moorman PG
    Expert Opin Drug Saf; 2014 Oct; 13(10):1375-82. PubMed ID: 25146351
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cancer prevention and screening practices among women at risk for hereditary breast and ovarian cancer after genetic counseling in the community setting.
    Morgan D; Sylvester H; Lucas FL; Miesfeldt S
    Fam Cancer; 2009; 8(4):277-87. PubMed ID: 19347608
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Uptake of risk-reducing salpingo-oophorectomy among female BRCA mutation carriers: experience at the National Cancer Center of Korea.
    Kim SI; Lim MC; Lee DO; Kong SY; Seo SS; Kang S; Lee ES; Park SY
    J Cancer Res Clin Oncol; 2016 Jan; 142(1):333-40. PubMed ID: 26438354
    [TBL] [Abstract][Full Text] [Related]  

  • 19. For Women, Lynch Syndrome Is About More than Colon Cancer.
    Parker WM; Hennig K; Burton-Chase AM
    Cancer Prev Res (Phila); 2019 Dec; 12(12):831-836. PubMed ID: 31554630
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hereditary gynecologic cancers.
    Mutch D; Denny L; Quinn M;
    Int J Gynaecol Obstet; 2014 Mar; 124(3):189-92. PubMed ID: 24429354
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.